Macrogol En Electrolyten Ratiopharm

Macrogol 3350 with electrolytes, the active ingredient in Macrogol En Electrolyten Ratiopharm, is an osmotic laxative presented as an oral solution for oral use. It treats constipation and is used for bowel preparation before diagnostic procedures in adults and children as directed by a healthcare professional.

GNH USA supplies Macrogol En Electrolyten Ratiopharm as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Macrogol En Electrolyten Ratiopharm is an osmotic laxative indicated for conditions affecting bowel motility and preparation for procedures.

- Constipation: softens stool and promotes regular bowel movements. - Bowel preparation before diagnostic procedures: provides effective colon cleansing for colonoscopy, sigmoidoscopy or radiographic studies. - Pre‑operative bowel cleansing: reduces fecal load prior to abdominal surgery.

Macrogol En Electrolyten Ratiopharm may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Abdominal bloating - Flatulence - Nausea - Mild abdominal cramps - Thirst - Mild electrolyte imbalance (e.g., slight sodium or potassium shift)

Serious or Rare Side Effects: - Severe dehydration - Significant electrolyte disturbances (hypernatremia, hyperkalemia, hyponatremia) - Allergic reactions (rash, urticaria, angioedema) - Severe abdominal pain - Rectal bleeding - Anaphylaxis (rare)

When using Macrogol En Electrolyten Ratiopharm, consider the following safety measures.

- Assess renal function: adjust use in patients with severe renal impairment. - Monitor electrolyte status: especially potassium and sodium levels during prolonged therapy. - Use with caution in elderly: increased risk of dehydration and electrolyte loss. - Avoid in known hypersensitivity to macrogol or any of the electrolytes. - Pregnancy and lactation: safety not established; use only if clearly needed. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Macrogol En Electrolyten Ratiopharm can interact with several medication classes; awareness helps prevent adverse outcomes.

Major Interactions (Avoid): - High‑dose diuretics: may exacerbate electrolyte loss. - Concurrent use of other osmotic laxatives or mineral oil: risk of excessive fluid loss. - Sodium‑containing IV fluids: potential hypernatremia. - Potassium‑sparing diuretics: risk of hyperkalemia. - Anticholinergic agents: may reduce laxative efficacy.

Moderate Interactions (Monitor Closely): - ACE inhibitors: monitor blood pressure and electrolytes. - NSAIDs: watch for changes in renal function. - Antibiotics that alter gut flora: may affect bowel response.